Catalyst Brief

← Calendar

Readoutin 14d

Veradermics, Inc. — VDPHL01

Phase 3 primary completion: Safety and Efficacy of VDPHL01 in Males With AGA.

Date
Dec 2026
Type
Readout
Indication
Androgenetic Alopecia

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.